Svlsf V, Llc - Net Worth and Insider Trading

Svlsf V, Llc Net Worth

The estimated net worth of Svlsf V, Llc is at least $532,005 dollars as of 2024-11-13. Svlsf V, Llc is the 10% Owner of Astria Therapeutics Inc and owns about 47,628 shares of Astria Therapeutics Inc (ATXS) stock worth over $532,005. Details can be seen in Svlsf V, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Svlsf V, Llc has not made any transactions after 2015-06-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Svlsf V, Llc

To

Svlsf V, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Svlsf V, Llc owns 4 companies in total, including Bicycle Therapeutics PLC (BCYC) , Sutro Biopharma Inc (STRO) , and X4 Pharmaceuticals Inc (XFOR) among others .

Click here to see the complete history of Svlsf V, Llc’s form 4 insider trades.

Insider Ownership Summary of Svlsf V, Llc

Ticker Comapny Transaction Date Type of Owner
BCYC Bicycle Therapeutics PLC 2019-05-22 10 percent owner
STRO Sutro Biopharma Inc 2018-09-26 10 percent owner
XFOR X4 Pharmaceuticals Inc 2017-11-15 10 percent owner
LIMIT LIMIT 2015-06-30 10 percent owner

Svlsf V, Llc Latest Holdings Summary

Svlsf V, Llc currently owns a total of 1 stock. Svlsf V, Llc owns 47,628 shares of Astria Therapeutics Inc (ATXS) as of June 30, 2015, with a value of $532,005.

Latest Holdings of Svlsf V, Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATXS Astria Therapeutics Inc 2015-06-30 47,628 11.17 532,005

Holding Weightings of Svlsf V, Llc


Svlsf V, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Svlsf V, Llc has made a total of 0 transactions in Astria Therapeutics Inc (ATXS) over the past 5 years. The most-recent trade in Astria Therapeutics Inc is the acquisition of 6,518 shares on June 30, 2015, which cost Svlsf V, Llc around $5 Million.

Insider Trading History of Svlsf V, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Svlsf V, Llc Trading Performance

GuruFocus tracks the stock performance after each of Svlsf V, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Svlsf V, Llc is -33.74%. GuruFocus also compares Svlsf V, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Svlsf V, Llc within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Svlsf V, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Svlsf V, Llc

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.33 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 12.12 LIMIT LIMIT LIMIT LIMIT LIMIT

Svlsf V, Llc Ownership Network

Ownership Network List of Svlsf V, Llc

No Data

Ownership Network Relation of Svlsf V, Llc

Insider Network Chart

Svlsf V, Llc Owned Company Details

What does Bicycle Therapeutics PLC do?

Who are the key executives at Bicycle Therapeutics PLC?

Svlsf V, Llc is the 10 percent owner of Bicycle Therapeutics PLC. Other key executives at Bicycle Therapeutics PLC include Chief Operating Officer Michael Skynner , Chief Accounting Officer Travis Alvin Thompson , and Chief Operating Officer Alistair Milnes .

Bicycle Therapeutics PLC (BCYC) Insider Trades Summary

Over the past 18 months, Svlsf V, Llc made no insider transaction in Bicycle Therapeutics PLC (BCYC). Other recent insider transactions involving Bicycle Therapeutics PLC (BCYC) include a net sale of 21,235 shares made by Kevin Lee , a net sale of 6,430 shares made by Michael Skynner , and a net sale of 6,430 shares made by Nigel Crockett .

In summary, during the past 3 months, insiders sold 6,528 shares of Bicycle Therapeutics PLC (BCYC) in total and bought 0 shares, with a net sale of 6,528 shares. During the past 18 months, 47,264 shares of Bicycle Therapeutics PLC (BCYC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 47,264 shares.

Bicycle Therapeutics PLC (BCYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bicycle Therapeutics PLC Insider Transactions

No Available Data

Svlsf V, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Svlsf V, Llc. You might contact Svlsf V, Llc via mailing address: C/o Sv Life Sciences Advisers, Llc, One Boston Place, Suite 3900, Boston Ma 02108.